On 4th-7th April, the WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) came to the agreement that a single dose of HPV vaccine delivers a level of protection against HPV infection that is comparable to two-dose HPV vaccine schedules. This is a huge step towards our shared vision of ensuring that girls globally grow up protected from cervical cancer.
This decision was made in consideration of evidence published over the last three years, demonstrating the immune responses of single doses of HPV vaccines, and their efficacy in preventing HPV infection.